UPDATED
·
2 MIN READ

COVID-19 (2019 novel coronavirus) resource center for physicians

The AMA is closely monitoring COVID-19 (2019 novel coronavirus) developments. Learn more with the AMA's COVID-19 resource center.

Public Health

A time to stand together

With expert resources and tireless advocacy, the AMA is your powerful ally against COVID-19.

·
12 MIN READ

CDC changes COVID isolation guidelines and COVID vaccine dose schedule with Sandra Fryhofer, MD

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about changes to COVID isolation guidelines and COVID vaccine dose schedule.

series
Public Health
AMA Update
·
12 MIN READ

CDC changes COVID isolation guidelines and COVID vaccine dose schedule with Sandra Fryhofer, MD [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about changes to COVID isolation guidelines and COVID vaccine dose schedule.

series
Public Health
AMA Update Podcast
·
11 MIN READ

COVID surge 2024, Wegovy side effect study and using AI in medicine with Andrea Garcia, JD, MPH

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about COVID surge updates, Wegovy side effects and more.

series
Public Health
AMA Update
·
11 MIN READ

COVID surge 2024, Wegovy side effect study and using AI in medicine with Andrea Garcia, JD, MPH [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about COVID surge updates, Wegovy side effects and more.

series
Public Health
AMA Update Podcast
·
11 MIN READ

Symptoms of new COVID variant JN.1, latest studies on Paxlovid rebound and Hydroxychloroquine [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about symptoms of new COVID-19 variant JN.1 and more.

series
Public Health
AMA Update Podcast
·
11 MIN READ

Symptoms of new COVID variant JN.1, latest studies on Paxlovid rebound and hydroxychloroquine

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about symptoms of new COVID-19 variant JN.1 and more.

series
Public Health
AMA Update
·
4 MIN READ

Top news stories from AMA Morning Rounds®: Week of Dec. 18, 2023

In the news: Google releases MedLM AI to answer medical questions, severe obesity on the rise among young children, JN.1 a COVID “variant of interest” and more.

Publications & Newsletters
·
6 MIN READ

JN.1 Omicron subvariant: Questions patients may have

As the U.S. confronts respiratory virus season, the COVID-19 Omicron subvariant JN.1 has emerged, quickly becoming a prevalent strain. Learn more.

Public Health